A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)

Sex: All

Ages: 18 Years – 55 Years

Healthy volunteers: Yes

Phase: PHASE1

Enrollment: 15

Sponsor: Merck Sharp & Dohme LLC

Summary

The purpose of this trial is to learn about a trial medicine called MK-1403. Researchers designed MK-1403 to treat a type of heart and blood vessel disease called atherosclerotic cardiovascular disease (ASCVD). Before giving a trial medicine to people with a health condition, researchers first do clinical trials in healthy people. This trial will help researchers learn about the safety of MK-1403 and if participants tolerate it. Tolerate means participants receive the trial medicine and they do not need to stop taking it due to health problems. The trial will also measure what happens to MK 1403 in a healthy person's body over time.

Eligibility Criteria

Inclusion Criteria: * Is in good health * Has a body mass index (BMI) ≥ 18 and ≤ 32 kg/m\^2 Exclusion Criteria: * Has history of cancer (malignancy) * Has a history of significant multiple and/or severe allergies

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07677163). StuddyBuddy aggregates publicly available trial information.